These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9133686)

  • 1. Regulations for radioiodine therapy in the United States: current status and the process of change.
    Vetter RJ
    Thyroid; 1997 Apr; 7(2):209-11. PubMed ID: 9133686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
    ; Sisson JC; Freitas J; McDougall IR; Dauer LT; Hurley JR; Brierley JD; Edinboro CH; Rosenthal D; Thomas MJ; Wexler JA; Asamoah E; Avram AM; Milas M; Greenlee C
    Thyroid; 2011 Apr; 21(4):335-46. PubMed ID: 21417738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.
    Gates VL; Carey JE; Siegel JA; Kaminski MS; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1230-6. PubMed ID: 9669400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulations and policies on radioiodine 131I therapy in Europe.
    Beckers C
    Thyroid; 1997 Apr; 7(2):221-4. PubMed ID: 9133689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose to patients and relatives incident to 131I therapy.
    Zanzonico PB
    Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
    Grigsby PW; Siegel BA; Baker S; Eichling JO
    JAMA; 2000 May; 283(17):2272-4. PubMed ID: 10807387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes].
    Wellner U; Eschner W; Hillger HW; Schicha H
    Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised Nuclear Regulatory Commission regulations for release of patients administered radioactive materials: outpatient iodine-131 anti-B1 therapy.
    Siegel JA
    J Nucl Med; 1998 Aug; 39(8 Suppl):28S-33S. PubMed ID: 9708568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.
    Rutar FJ; Augustine SC; Colcher D; Siegel JA; Jacobson DA; Tempero MA; Dukat VJ; Hohenstein MA; Gobar LS; Vose JM
    J Nucl Med; 2001 Jun; 42(6):907-15. PubMed ID: 11390555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I.
    Siegel JA; Marcus CS; Stabin MG
    Health Phys; 2007 Dec; 93(6):667-77. PubMed ID: 17993847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
    Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
    Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the activity of radiopharmaceutical dosages: Nuclear Regulatory Commission. Proposed rule.
    Fed Regist; 1981 Sep; 46(169):43840-2. PubMed ID: 10252126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for better methods to determine release criteria for patients administered radioactive material.
    Sparks RB; Siegel JA; Wahl RL
    Health Phys; 1998 Oct; 75(4):385-8. PubMed ID: 9753361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
    Parthasarathy KL; Crawford ES
    J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactivity in municipal sewage and sludge.
    Martin JE; Fenner FD
    Public Health Rep; 1997; 112(4):308-16; discussion 317-8. PubMed ID: 9258296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AEC/NRC 30 mCi rule: regulatory origins and clinical consequences for 131I remnant ablative doses.
    Siegel JA; Silberstein EB
    Thyroid; 2014 Nov; 24(11):1625-35. PubMed ID: 25045970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-body radiation doses following radioiodine therapy.
    Leslie WD; Havelock J; Palser R; Abrams DN
    Nucl Med Commun; 2002 Nov; 23(11):1091-7. PubMed ID: 12411838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor corrections, clarifying changes, and a minor policy change--NRC. Final rule.
    Fed Regist; 1998 Jul; 63(141):39477-83. PubMed ID: 10181512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.